Erratum (Gastrointestinal Endoscopy (2012) 76(1) (18–24), (S0016510712001940), (10.1016/j.gie.2012.02.029));Guidelines for endoscopy in pregnant and lactating women

Gastrointestinal Endoscopy

Volumn 76, Issue 1, 2012, Pages 18-24

  Shergill, Amandeep K ^a   Ben Menachem, Tamir ^a   Chandrasekhara, Vinay ^a   Chathadi, Krishnavel ^a   Decker, G Anton ^a   Evans, John A ^a   Early, Dana S ^a   Fanelli, Robert D ^a   Fisher, Deborah A ^a   Foley, Kimberly Q ^a   Fukami, Norio ^a   Hwang, Joo Ha ^a   Jain, Rajeev ^a   Jue, Terry L ^a   Khan, Khalid M ^a   Lightdale, Jennifer ^a   Pasha, Shabana F ^a   Sharaf, Ravi N ^a   Dominitz, Jason A ^a   Cash, Brooks D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; DIAZEPAM; ERYTHROMYCIN; FENTANYL; FLUMAZENIL; GLUCAGON; LIDOCAINE; MACROGOL; METRONIDAZOLE; MIDAZOLAM; MORPHINE; NALOXONE; NARCOTIC ANALGESIC AGENT; NITROFURANTOIN; OFLOXACIN; PENICILLIN DERIVATIVE; PETHIDINE; PROPOFOL; QUINOLONE DERIVATIVE; SIMETHICONE; SODIUM DIHYDROGEN PHOSPHATE; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ABDOMINAL PAIN; BILE DUCT INJURY; BLOOD BRAIN BARRIER; BLOOD PLACENTA BARRIER; BREAST FEEDING; CAUTERIZATION; CHOLANGITIS; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMMON BILE DUCT STONE; DEEP SEDATION; DELIVERY; DIARRHEA; DISEASE SEVERITY; DRUG CLASSIFICATION; DRUG SAFETY; DYSPHAGIA; ECLAMPSIA; FETUS DISTRESS; FETUS HEART RATE; FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; HYPOTENSION; LACTATION; NAUSEA AND VOMITING; ODYNOPHAGIA; OPIATE ADDICTION; PANCREATITIS; PATIENT CARE; PATIENT POSITIONING; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; RISK BENEFIT ANALYSIS; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE; THIRD TRIMESTER PREGNANCY; TRANQUILIZING ACTIVITY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UTERUS CONTRACTION; WITHDRAWAL SYNDROME;

EID: 84862673701     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2013.03.1312     Document Type: Erratum

References (61)

1. Qureshi WA, Rajan E, Adler DG, et al. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc 2005;61:357-62.
2. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
3. Kammerer WS. Non-obstetric surgery during pregnancy. Med Clin North Am 1979;63:1157-64.
4. Cappell MS. Risks versus benefits of gastrointestinal endoscopy during pregnancy. Nat Rev Gastroenterol Hepatol 2011;8:610-34.
5. Allaert SE, Carlier SP, Weyne LP, et al. First trimester anesthesia exposure and fetal outcome: a review. Acta Anaesthesiol Belg 2007;58:119-23.
6. Brent RL. Radiation teratogenesis. Teratology 1980;21:281-98.
7. Brent RL. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol 1989;16:347-68.
8. Cappell MS. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am 2003;32:123-79.
9. Duncan PG, Pope WD, Cohen MM, et al. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 1986;64:790-4.
10. Cohen-Kerem R, Railton C, Oren D, et al. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg 2005;190:467-73.
11. Cheek TG, Baird E. Anesthesia for nonobstetric surgery: maternal and fetal considerations. Clin Obstet Gynecol 2009;52:535-45.
12. Briggs GG, Greeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
13. Heinonen OP, Stone D, Shapiro S. Birth defects and drugs in pregnancy. Boston: John Wright; 1982.
14. Cunningham FG, Gant NF, Leveno KJ. Analgesia and sedation. In: William's Obstetrics, 21st ed, New York: McGraw-Hill; 2001. p. 537-63.
15. Martin LV, Jurand A. The absence of teratogenic effects of some analgesics used in anaesthesia: additional evidence from a mouse model. Anaesthesia 1992;47:473-6.
16. Hibbard BM, Rosen M, Davies D. Placental transfer of naloxone. Br J Anaesth 1986;58:45-8.
17. Morse J, Bamias G. Ability to reverse deeper levels of unintended sedation. Digestion 2010;82:94-6.
18. Ornoy A, Arnon J, Shechtman S, et al. Is benzodiazepine use during pregnancy really teratogenic? Reprod Toxicol 1998;12:511-5.
19. Dolovich LR, Addis A, Vaillancourt JMR, et al. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-controlled studies. BMJ 1998;317:839-43.
20. Laegreid L, Olegard R, Wahlstrom J, et al. Teratogenic effects of benzodiazepine use during pregnancy. J Pediatr 1989;114:126-31.
21. Cagiano R, De Salvia MA, Giustino A, et al. Behavioral changes produced in rats by developmental exposure to flumazenil, a benzodiazepine receptor antagonist. Prog Neuropsychopharmacol Biol Psychiatry 1993;17:151-9.
22. Gin T. Propofol during pregnancy. Acta Anaesthesiol Sin 1994;32:127-32.
23. Physician's desk reference. 56th ed. Montvale (NJ): Medical Economics Co; 2002.
24. Mahadevan U, Kane S. American Gastroenterological Association Institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006;131:283-311.
25. American Society of Anesthesiologists (ASA) and the American College of Obstetricians and Gynecologists (ACOG) Statement on non obstetric surgery during pregnancy 10/2009. http://www.asahq.org/For-Members/Standards-Guidelines-and- Statements.aspx. Accessed October 25, 2011.
26. Banerjee S, Shen B, Baron TH, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008;67:791-8.
27. Ell C, Fischbach W, Keller R, et al. A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy. Endoscopy 2003;35:300-4.
28. Carson MP, Gibson PS. Perioperative management of the pregnant patient. Rosene-Montella K, Keely E, Barbour LA, et al, editors. Medical care of the pregnant patient, 2nd ed. Philadelphia: ACP press; 2008.
29. Debby A, Golan A, Sadan O, et al. Clinical utility of esophagogastroduodenoscopy in the management of recurrent and intractable vomiting in pregnancy. J Reprod Med 2008;53:347-51.
30. Cappell MS, Colon VJ, Sidhom OA. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal outcome with comparison control groups. Am J Gastroenterol 1996;91:348-54.
31. Cappell MS. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am 2003;32:123-79.
32. Cappell MS, Sidhom O, Colon V. A study at ten medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci 1996;41:2353-60.
33. Frank B. Endoscopy in pregnancy. In: Karlstadt RG, Surawicz CM, Croitoru R, editors. Gastrointestinal disorders during pregnancy. Arlington (VA): American College of Gastroenterology;1994. p. 24-9.
34. Cappell MS, Fox SR, Gorrepati N. Safety and efficacy of colonoscopy during pregnancy: an analysis of pregnancy outcome in 20 patients. J Reprod Med 2010;55:115-23.
35. Tham TCK, Vandervoort J, Wong RCK, et al. Safety of ERCP during pregnancy. Am J Gastroenterol 2003;987:308-11.
36. Axelrad AM, Fleischer DE, Strack LL, et al. Performance of ERCP for symptomatic choledocholithiasis during pregnancy: techniques to increase safety and improve patient management. Am J Gastroenterol 1994;89:109-12.
37. Jamidar PA, Beck GJ, Hoffman BJ, et al. Endoscopic retrograde cholangiopancreatography in pregnancy. Am J Gastroenterol 1995;90:1263-76.
38. Kahaleh M, Hartwell GD, Arseneau KO, et al. Safety and efficacy of ERCP in pregnancy. Gastrointest Endosc 2004;60:287-92.
39. Tang SJ, Mayo MJ, Rodriguez-Frias E, et al. Safety and utility of ERCP during pregnancy. Gastrointest Endosc 2009;69:453-61.
40. Samara ET, Stratakis J, Enele Melono JM, et al. Therapeutic ERCP and pregnancy: is the radiation risk for the conceptus trivial? Gastrointest Endosc 2009;69:824-31.
41. Baron TH, Schueler BA. Pregnancy and radiation exposure during therapeutic ERCP: time to put the baby to bed? Gastrointest Endosc 2009;69:832-4.
42. Johlin FC, Pelsang RE, Greenleaf M. Phantom study to determine radiation exposure to medical personnel involved in ERCP fluoroscopy and its reduction through equipment and behavior modifications.AmJ Gastroenterol 2002;97:893-7.
43. Medical radiation exposure of pregnant and potentially pregnant women. NCRP Report no. 54. Washington DC: National Council on Radiation Protection Measurements; 1977.
44. Akcakaya A, Ozkan OV, Okan I, et al. Endoscopic retrograde cholangiopancreatography during pregnancy without radiation. World J Gastroenterol 2009;5:3649-52.
45. Shelton J, Linder JD, Rivera-Alsina ME, et al. Commitment, confirmation, and clearance: new techniques for nonradiation ERCP during pregnancy (with videos). Gastrointest Endosc 2008;67:364-8.
46. Chong VH, Jalihal A. Endoscopic management of biliary disorders during pregnancy. Hepatobiliary Pancreat Dis Int 2010;9:180-5.
47. Sharma SS, Maharshi S. Two stage endoscopic approach for management of choledocholithiasis during pregnancy. J Gastrointestin Liver Dis 2008;7:183-5.
48. Einarson A, Bailey B, Inocencion G, et al. Accidental electric shock in pregnancy: a prospective cohort study. Am J Obstet Gynecol 1997;176:678-81.
49. Matheson I, Lunde PK, Bredesen JE. Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br J Clin Pharmacol 1990;30:787-93.
50. Nitsun MJ, Szokol JW, Saleh HJ, et al. Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk. Clin Pharmacol Ther 2006;79:549-57.
51. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137-50.
52. Steer PL, Biddle CJ, Marley WS, et al. Concentration of fentanyl in colostrum after an analgesic dose. Can J Anaesth 1992;39:231-5.
53. Peiker G, Muller B, Ihn W, et al. Ausscheidung von pethidin durch die muttermilch [In German with English translation by author]. Excretion of pethidine in mother's milk. Zentralbl Gynakol 1980;102:537-41.
54. Freeborn SF, Calvert RT, Black P, et al. Saliva and blood pethidine concentrations in the mother and the newborn baby. Br J Obstet Gynaecol 1980;87:966-9.
55. Wittels B, Scott DT, Sinatra RS. Exogenous opioids in human breast milk and acute neonatal neurobehavior: a preliminary study. Anesthesiology 1990;73:864-9.
56. Ito S. Drug therapy for breast-feeding women. N Engl J Med 2000;343:118-26.
57. National Library of Medicine, Drugs and Lactation Database. Meperidine. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed October 26, 2011.
58. Dailland P, Cockshott ID, Lirzin JD, et al. Intravenous propofol during cesarean section: placental transfer, concentrations in breast milk, and neonatal effects: a preliminary study. Anesthesiology 1989;71:827-34.
59. National Library of Medicine, Drugs and Lactation Database. Naloxone. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed October 26, 2011.
60. Giamarellou HE, Kolokythas E, Petrikkos G, et al. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989;87:49S-51S.
61. Mathew JL. Effect of maternal antibiotics on breast feeding infants. Postgrad Med J 2004;80:196-200.